Global Cord Blood Corporation (CO) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2020
March 11, 2020 4:16 PM EDT3Q20 Added 23,387 New SubscribersRevenues Up 31.7% YoY to RMB334.7 Million ($48.1 Million)Operating Income Up 65.1% YoY to RMB152.9 Million ($22.0 Million) Non-GAAP Operating Income Up 56.7% YoY to RMB165.0 Million ($23.7 Million)Conference Call to be Held on March 12, 2020, at 8:00 a.m. ET
HONG KONG, March 11, 2020 /PRNewswire/ --Â Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for the third quarter and first nine months of fiscal year 2020 ended December 31,... More
